Posted On: 10/14/2014 12:04:02 PM
Post# of 30067
One mistake from the article in AlzheimersNewsToday-
"Following these encouraging results, the company is planning to expand the inclusion criteria to include patients diagnosed with mild Alzheimer’s disease. This study will enroll 68 additional subjects, including 34 mild-to-severe Alzheimer’s patients and 34 healthy controls. Amarantus predicts completing this enrollment in the fourth quarter of 2015, and will announce data from an in-depth analysis from the full cohort of 140 subjects (72 patients + 68 patient extension) shortly thereafter."
Should read-
Based on the strength of these results, the company has expanded the inclusion criteria to also enroll patients diagnosed with mild Alzheimer's disease. 68 additional subjects will be recruited, including 34 mild-to-severe Alzheimer's patients, and 34 healthy controls. Amarantus anticipates completing enrollment of the 68 patient LP-002 extension in the fourth quarter and will announce data from an in-depth analysis from the full cohort of 140 subjects (72 patients + 68 patient extension) shortly thereafter.
"Following these encouraging results, the company is planning to expand the inclusion criteria to include patients diagnosed with mild Alzheimer’s disease. This study will enroll 68 additional subjects, including 34 mild-to-severe Alzheimer’s patients and 34 healthy controls. Amarantus predicts completing this enrollment in the fourth quarter of 2015, and will announce data from an in-depth analysis from the full cohort of 140 subjects (72 patients + 68 patient extension) shortly thereafter."
Should read-
Based on the strength of these results, the company has expanded the inclusion criteria to also enroll patients diagnosed with mild Alzheimer's disease. 68 additional subjects will be recruited, including 34 mild-to-severe Alzheimer's patients, and 34 healthy controls. Amarantus anticipates completing enrollment of the 68 patient LP-002 extension in the fourth quarter and will announce data from an in-depth analysis from the full cohort of 140 subjects (72 patients + 68 patient extension) shortly thereafter.
(0)
(0)
